Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Cramp Daniella	2. Issuer Name and Ticker or Trading Symbol ALERE INC. [ ALR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                      _____ 10% Owner __ X __ Officer (give title below)      _____ Other (specify below) Global Pres., Cardiometabolic
(Last)          (First)          (Middle) 51 SAWYER ROAD, SUITE 200	3. Date of Earliest Transaction (MM/DD/YYYY) 8/31/2017
(Street) WALTHAM, MA 02453 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	8/31/2017		M		6667	A	(1)	30552	D
Common Stock	8/31/2017		F		2505	D	$49.46	28047	D
Common Stock	8/31/2017		M		8308	A	$48.14	36355	D
Common Stock	8/31/2017		F		8086   (6)	D	$49.46	28269	D
Common Stock	8/31/2017		M		1692	A	$48.14	29961	D
Common Stock	8/31/2017		F		1663   (6)	D	$49.46	28298	D
Common Stock								275	I	See footnote 7.   (7)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	8/31/2017		M			6667	(2)	(2)	Common Stock	6667	$0	0	D
Employee Stock Option (right to buy)	$48.14	8/31/2017		M			8308	(3)	8/31/2017   (4)	Common Stock	8308	(5)	0	D
Employee Stock Option (right to buy)	$48.14	8/31/2017		M			1692	(3)	8/31/2017   (4)	Common Stock	1692	(5)	0	D

Explanation of Responses:
(1)	Each restricted stock unit represents a contingent right to receive one share of Alere common stock.
(2)	On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17).
(3)	These options became exercisable in four equal annual installments beginning August 31, 2008.
(4)	The Options were scheduled to expire on August 31, 2017.
(5)	This derivative security does not have a price.
(6)	Represents withholding of shares of Company common stock to satisfy exercise price and tax liability associated with exercise of stock options shown above.
(7)	These securities are owned by the Cramp Family Trust for which the reporting person and her spouse are the trustees.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Cramp Daniella 51 SAWYER ROAD, SUITE 200 WALTHAM, MA 02453			Global Pres., Cardiometabolic

Signatures
/s/ Douglas Barry, Attorney-in-Fact		9/5/2017
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.